ZEAL ZEAL Network SE : Bullish and Bearish Analyst Opinions

Sentiment & Price 2 ideas • 2 voices • 2 sources
Sentiment Gauge
0
Bull
0
Bear
0
Watch
Bull 50% Bear 50%
Price & Sentiment
Loading chart...
Recent News Top Views
No recent news for ZEAL
No theses available
Feed
All Sources
YouTube
Twitter
Reddit
Substack
Insider
News
Loading...
All directions
▲ Long
▼ Short
◦ Others
Any score
LOW+
MED+
HIGH
12:10
Mar 06
Abeer Abu Omar Reporter, Bloomberg London Bloomberg Markets
Zealand Pharma shares plunged ~33% (trading in Denmark, implies ADR impact). Their weight loss drug showed only ~10.7% loss over 42 weeks. The weight loss market is a duopoly (Novo/Lilly). To compete, a new entrant needs superior data. Zealand's data is significantly "shorter than rivals," rendering their product commercially unviable in a crowded market. SHORT. The market is pricing out the probability of this drug's success. Potential M&A target for big pharma looking for pipeline assets despite weak data.
ZEAL
08:07
Mar 06
ZEALAND PHARMA SHARES DROP BY RECORD 32% ON OBESITY DRUG DATA
ZEAL

About ZEAL Analyst Coverage

Buzzberg tracks ZEAL (ZEAL Network SE) across 2 sources. 0 bullish vs 2 bearish calls from 2 analysts. Sentiment: mixed to bearish. 2 total trade ideas tracked.